Development of an Activity-Based Probe for Autotaxin

被引:10
|
作者
Cavalli, Silvia [1 ,2 ]
Houben, Anna J. S. [1 ]
Albers, Harald M. H. G. [1 ]
van Tilburg, Erica W. [1 ,3 ]
de Ru, Arnoud [4 ]
Aoki, Junken [5 ]
van Veelen, Peter [4 ]
Moolenaar, Wouter H. [1 ]
Ovaa, Huib [1 ]
机构
[1] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands
[2] Biomed Res Inst, Networking Ctr Bioengn Biomat & Nanomed, CIBER BBN, Barcelona 08028, Spain
[3] Erasmus MC, Dept Nucl Med, NL-3015 CE Rotterdam, Netherlands
[4] Leiden Univ, Med Ctr, Div Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands
[5] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan
关键词
autotaxin; biomarkers; enzymes; inhibitors; lysophospholipase D; PROTEIN-TYROSINE PHOSPHATASES; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE-D; FLUORESCENT-PROBES; NEUROPATHIC PAIN; ENZYME; LPA; IDENTIFICATION; INHIBITOR; MOTILITY;
D O I
10.1002/cbic.201000349
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autotaxin (ATX), or ecto-nucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), is a secreted lysophospholipase D that hydrolyses lysophosphatidylcholine into the lipid mediator lysophosphatidic acid (LPA), a mitogen and chemoattractant for many cell types. ATX has been implicated in tumour progression and inflammation, and might serve as a biomarker. Here we describe the development of a fluorescent activity-based probe that covalently binds to the active site of ATX. The probe consists of a lysophospholipid-based backbone linked to a trapping moiety that becomes reactive after phosphate ester hydrolysis, and a Cy5 fluorescent dye to allow visualisation of active ATX. The probe reacts specifically with the three known isoforms of ATX, it competes with small-molecule inhibitors for binding to ATX and allows ATX activity in plasma to be determined. Our activity-based reporter will be useful for monitoring ATX activity in biological fluids and for inhibitor screening.
引用
收藏
页码:2311 / 2317
页数:7
相关论文
共 50 条
  • [1] Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs
    North, E. Jeffrey
    Osborne, Daniel A.
    Bridson, Peter K.
    Baker, Daniel L.
    Parrill, Abby L.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (09) : 3433 - 3442
  • [2] Autotaxin in embryonic development
    Moolenaar, Wouter H.
    Houben, Anna J. S.
    Lee, Shyh-Jye
    van Meeteren, Laurens A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2013, 1831 (01): : 13 - 19
  • [3] Design and Development of Autotaxin Inhibitors
    Jia, Yi
    Li, Yan
    Xu, Xu-Dong
    Tian, Yu
    Shang, Hai
    PHARMACEUTICALS, 2021, 14 (11)
  • [4] Specific increase in serum autotaxin activity in patients with pancreatic cancer
    Nakai, Yousuke
    Ikeda, Hitoshi
    Nakamura, Kazuhiro
    Kume, Yukio
    Fujishiro, Mitsuhiro
    Sasahira, Naoki
    Hirano, Kenji
    Isayama, Hiroyuki
    Tada, Minoru
    Kawabe, Takao
    Komatsu, Yutaka
    Omata, Masao
    Aoki, Junken
    Koike, Kazuhiko
    Yatomi, Yutaka
    CLINICAL BIOCHEMISTRY, 2011, 44 (8-9) : 576 - 581
  • [5] Development of an acid ceramidase activity-based probe
    Ouairy, Cecile M. J.
    Ferraz, Maria J.
    Boot, Rolf G.
    Baggelaar, Marc P.
    van der Stelt, Mario
    Appelman, Monique
    van der Marel, Gijsbert A.
    Florea, Bogdan I.
    Aerts, Johannes M. F. G.
    Overkleeft, Herman S.
    CHEMICAL COMMUNICATIONS, 2015, 51 (28) : 6161 - 6163
  • [6] Development of an activity-based probe for amyloid β-hydrolyzing antibodies
    Taguchi, Hiroaki
    Fujita, Yoshio
    Tsuda, Yuko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (09) : 2210 - 2213
  • [7] Development of an activity-based probe for acyl-protein thioesterases
    Garland, Megan
    Schulze, Christopher J.
    Foe, Ian T.
    van der Linden, Wouter A.
    Child, Matthew A.
    Bogyo, Matthew
    PLOS ONE, 2018, 13 (01):
  • [8] Increased autotaxin activity in multiple sclerosis
    Zahednasab, Hamid
    Balood, Mohammad
    Harirchian, Mohammad Hossein
    Mesbah-Namin, Seyed Alireza
    Rahimian, Nasrin
    Siroos, Bahaadin
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 273 (1-2) : 120 - 123
  • [9] Discovery and Optimization of Boronic Acid Based Inhibitors of Autotaxin
    Albers, Harald M. H. G.
    van Meeteren, Laurens A.
    Egan, David A.
    van Tilburg, Erica W.
    Moolenaar, Wouter H.
    Ovaa, Huib
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (13) : 4958 - 4967
  • [10] Novel point mutations attenuate autotaxin activity
    Koh, Eunjin
    Bandle, Russell W.
    Roberts, David D.
    Stracke, Mary L.
    Clair, Timothy
    LIPIDS IN HEALTH AND DISEASE, 2009, 8